MED September/October 2017

Page 36

Customized care for heart stent patients is here – ONLY AT SANFORD HEART HOSPITAL. Sanford Heart is proud to be part of a health system that has focused on integrating genomic medicine into primary care, which is dramatically changing how we deliver care to your patients. Now with one simple genetic test – not available anywhere else in the region – heart stent patients can significantly reduce their risk of future heart attacks. This test allows our experts to pinpoint the most effective anti-clotting medication for each patient, based on their DNA.

National study* reveals vital information for patients with heart stents About 30% of all patients have a genetic deficiency that impairs how they react to Plavix (clopidogrel), which increases the risk of heart attack or stroke. *Sanford Heart is a participant in this study

Call (605) 312-2278 to learn if this genetic test is right for your patients.

Tom Stys, MD, FACC, FSCAI

T H I N K H EA RT T H I N K U S . CO M /PL AV I X 013000-00452 7/17

Medical Director of Cardiology Services at Sanford Heart Hospital


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
MED September/October 2017 by MED- (Midwest Medical Edition) - Issuu